Evidence map›Paper›PMID 33969420›Full record

ReviewDisease models & mechanisms2021

It takes a village: microbiota, parainflammation, paligenosis and bystander effects in colorectal cancer initiation.

Xingmin Wang, Ram Babu Undi, Naushad Ali, Mark M Huycke

Open access · goldAbstract readReview
In one paragraph

Review in Disease models & mechanisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Regulation of STK38 by autophagy governs YAP1 activity during paligenosis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Inactivation of glutathioneGut microbes · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. F4/80Gastroenterology · 2023
    Article
  12. Genetic heterogeneity of colorectal cancer and the microbiome.World journal of gastrointestinal oncology · 2023
    Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Xingmin WangNantong Institute of Genetics and Reproductive Medicine, Nantong Maternity and Child Healthcare Hospital, Nantong University, Nantong, Jiangsu 226018, China.ORCID 0000-0001-5655-9012
Ram Babu UndiDepartment of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.ORCID 0000-0001-5061-7066
Naushad AliDepartment of Internal Medicine, Section of Digestive Diseases and Nutrition, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.ORCID 0000-0002-0058-7396
Mark M HuyckeDepartment of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.ORCID 0000-0002-6110-5629
University of Oklahoma Health Sciences Center · USJiangsu University · CN

Funding

Proteomics CoreP20GM103447 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Mark L Lang · 2012 to 2026
$60.2M
Microbiome-triggered reprogramming and mutation of colon epithelial cells leading to tumor stem-like cellsR01CA230641 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI HUYCKE, MARK M · 2019 to 2023
$2.3M
NCI NIH HHS R01 CA230641NIGMS NIH HHS P20 GM103447
6 · The paper itself

Abstract

Sporadic colorectal cancer (CRC) is a leading cause of worldwide cancer mortality. It arises from a complex milieu of host and environmental factors, including genetic and epigenetic changes in colon epithelial cells that undergo mutation, selection, clonal expansion, and transformation. The gut microbiota has recently gained increasing recognition as an additional important factor contributing to CRC. Several gut bacteria are known to initiate CRC in animal models and have been associated with human CRC. In this Review, we discuss the factors that contribute to CRC and the role of the gut microbiota, focusing on a recently described mechanism for cancer initiation, the so-called microbiota-induced bystander effect (MIBE). In this cancer mechanism, microbiota-driven parainflammation is believed to act as a source of endogenous mutation, epigenetic change and induced pluripotency, leading to the cancerous transformation of colon epithelial cells. This theory links the gut microbiota to key risk factors and common histologic features of sporadic CRC. MIBE is analogous to the well-characterized radiation-induced bystander effect. Both phenomena drive DNA damage, chromosomal instability, stress response signaling, altered gene expression, epigenetic modification and cellular proliferation in bystander cells. Myeloid-derived cells are important effectors in both phenomena. A better understanding of the interactions between the gut microbiota and mucosal immune effector cells that generate bystander effects can potentially identify triggers for parainflammation, and gain new insights into CRC prevention.

Indexed as

Bystander EffectGastrointestinal MicrobiomeAnimalsCarcinogenesisColorectal NeoplasmsDysbiosisHumansInflammationBacteriaCancer stem cellsCarcinogenesisCell dedifferentiationCell-of-originChromosomal instabilityColorectal neoplasmsDNA damageDoublecortin-like kinase 1Gut microbiomeMutationNeoplastic cell transformationPaligenosisRadiation-induced bystander effect

Identifiers

PMID33969420
PMCPMC10621663
OpenAlexW3162204645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.